Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Combo pills do not save patients money

Leslie Ramirez, MD
Meds
July 7, 2010
Share
Tweet
Share

Many prescription medicines are actually two or more medicines combined into one pill or package. True, this packaging is convenient– but you can often save money by buying your medicine as its separate components. Let’s look at some examples:

Lotrel blood pressure pills. This is actually a combination of two blood pressure medicines: amlodipine and benazapril. Lotrel, the combo pill, is available in a generic form, as are it’s two individual ingredients.

However, the pricing works out as follows (Costco prices):

Lotrel 10/20 (generic), 30 tabs: $70

VS

Amlodipine 10 mg, 30 tabs: $6

Benazepril 20 mg, 30 tabs: $6

Total: $12

I am really not sure the reason for this price disparity but I have some inklings.

I know that Big Pharma (BP) releases their combo products long after the original medication has been released. Usually by adding a little bit of diuretic, or in this case the amlodipine, a calcium channel blocker. This enables BP to get a brand new patent for these combo pills. So they are able to keep the combo pill price high long after the individual ingredient prices go generic and become much cheaper.

In the case of Lotrel, while the combo pill is also technically generic, its makers may be enjoying the one year manufacturing exclusivity that keeps generic prices initially high. Or it may be an expensive manufacturing process– but why pay for that?

Moving on to my latest favorite outrage:

Prevpac, a treatment for H.pylori. H.pylori is the bacteria that can cause ulcers and gastritis. Prevpacs are a two week treatment course of three different medicines all prepackaged for you. For us docs they are super easy to order. However, Prevpacs are not generic, but the three components of Prevpac ARE available as generic. Let’s look at how the pricing shakes out:

Prevpac, 2 week supply: $396

VS

amoxicillin 500 mg, 4 tabs x 2 weeks- $8

clarithromycin 500 mg, 2 tabs x 2 weeks- $17

lansoprazole 30 mg, 2 tabs x 2 weeks- $63

Total of the three components: $88

ADVERTISEMENT

These are just two examples of how buying prescriptions “a la carte” saves you big money over medicine “combo platters”. Ask your doctor if you are on any of these combination treatments and see if there might be a cheaper alternative.

Leslie Ramirez is an internal medicine physician and founder of Leslie’s List, which provides information that enables all patients, but especially the uninsured and underinsured, to find more affordable medications and health care services.

Submit a guest post and be heard.

Prev

MKSAP: 68-year-old woman with difficulty seeing out of her left eye

July 7, 2010 Kevin 1
…
Next

Emergency room waits grow as more people become insured

July 8, 2010 Kevin 7
…

Tagged as: Medications

Post navigation

< Previous Post
MKSAP: 68-year-old woman with difficulty seeing out of her left eye
Next Post >
Emergency room waits grow as more people become insured

ADVERTISEMENT

More by Leslie Ramirez, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Why are some generic drugs so expensive?

    Leslie Ramirez, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Options when your drug copays are too expensive

    Leslie Ramirez, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Where an adult can get low cost vaccines

    Leslie Ramirez, MD

More in Meds

  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • Why South Asians in the U.S. face a silent heart disease crisis

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Why chronic pain patients and doctors are both under attack

      Richard A. Lawhern, PhD | Conditions
    • The overlooked power of billing in primary care

      Jerina Gani, MD, MPH | Physician
    • The quiet work of dying: a hospice nurse’s reflection

      Christopher M. Smith, RN | Conditions
    • A systemic plan for health worker well-being [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • Why South Asians in the U.S. face a silent heart disease crisis

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Why chronic pain patients and doctors are both under attack

      Richard A. Lawhern, PhD | Conditions
    • The overlooked power of billing in primary care

      Jerina Gani, MD, MPH | Physician
    • The quiet work of dying: a hospice nurse’s reflection

      Christopher M. Smith, RN | Conditions
    • A systemic plan for health worker well-being [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Combo pills do not save patients money
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...